Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GROWTH FRACTIONS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 65 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laprie, C; Abadie, J; Amardeilh, MF; Net, JLLE; Lagadic, M; Delverdier, M
      MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma

      VETERINARY DERMATOLOGY
    2. Espay, AJ; Azzarelli, B; Williams, LS; Bodensteiner, JB
      Recurrence in pituitary adenomas in childhood and adolescence

      JOURNAL OF CHILD NEUROLOGY
    3. Gonzalez-Campora, R; Ruiz, MRG; Ramirez, FV; Martin, JJR; Santos, JMF; Martos, MDR; Pascual, AG
      Apoptosis in breast carcinoma

      PATHOLOGY RESEARCH AND PRACTICE
    4. Gontero, P; Casetta, G; Zitella, A; Ballario, R; Pacchioni, D; Magnani, C; Muir, GH; Tizzani, A
      Evaluation of p53 protein overexpression, ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder

      EUROPEAN UROLOGY
    5. Lebret, T; Becette, V; Herve, JM; Molinie, V; Barre, P; Lugagne, PM; Gentille, A; Baglin, AC; Botto, H
      Prognostic value of MIB-1 antibody labeling index to predict response to bacillus Calmette-Guerin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer

      EUROPEAN UROLOGY
    6. Nieto, A; Pena, L; Perez-Alenza, MD; Sanchez, MA; Flores, JM; Castano, M
      Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: Clinical and pathologic associations and prognostic significance

      VETERINARY PATHOLOGY
    7. Krause, FS; Feil, G; Bichler, KH
      Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer

      ANTICANCER RESEARCH
    8. Korabiowska, M; Brinck, U; Middel, P; Brinkman, U; Berger, H; Radzun, HJ; Ruschenburg, I; Droese, M
      Proliferative activity in the progression of pigmented skin lesions, diagnostic and prognostic significance

      ANTICANCER RESEARCH
    9. Messai, H; Khatib, AM; Lebrun, G; Aubin, P; Florina, M; Jean, F; Mitrovic, DR
      Endothelin-1 in monolayer cultures of articular chondrocytes from young and old rats: regulation by growth factors and cytokines

      MECHANISMS OF AGEING AND DEVELOPMENT
    10. Helpap, B; Kollermann, J
      Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: A contribution to the new WHO classification of urothelial tumors of the urinary bladder

      HUMAN PATHOLOGY
    11. Oosterhuis, JWA; Schapers, RFM; Janssen-Heijnen, MLG; Smeets, AWGB; Pauwels, RPE
      MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder - Clinical significance and comparison with other prognostic factors

      CANCER
    12. Klein, CL; Wagner, M; Kirkpatrick, CJ; Van Kooten, TG
      A new quantitative test method for cell proliferation based on detection of the Ki-67 protein

      JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
    13. Naidich, MJ; Russell, EJ
      Current approaches to imaging of the sellar region and pituitary

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    14. Stavropoulos, NE; Ioachim, E; Pappa, L; Hastazeris, K; Agnantis, NJ
      Antiproliferative activity of interferon gamma in superficial bladder cancer

      ANTICANCER RESEARCH
    15. Midulla, C; De Iorio, P; Nagar, C; Pisani, T; Cenci, M; Valli, C; Nofroni, I; Vecchione, A
      Immunohistochemical expression of p53, nm23-HI, Ki67 and DNA ploidy: Correlation with lymph node status and other clinical pathologic parameters in breast cancer

      ANTICANCER RESEARCH
    16. Tomobe, M; Shimazui, T; Uchida, K; Hinotsu, S; Akaza, H
      Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor

      JOURNAL OF UROLOGY
    17. Ono, S; Tokiwa, K; Iwai, N
      Cellular activity in the gallbladder of children with anomalous arrangement of the pancreaticobiliary duct

      JOURNAL OF PEDIATRIC SURGERY
    18. Kallakury, BVS; Sheehan, CE; Rhee, SJ; Fisher, HAG; Kaufman, RP; Rifkin, MD; Ross, JS
      The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma - A comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34(cdc2)

      CANCER
    19. Huuhtanen, RL; Blomqvist, CP; Wiklund, TA; Bohling, TO; Virolainen, MJ; Tukiainen, EJ; Tribukait, B; Andersson, LC
      Comparison of the Ki-67 score and S-phase fraction as prognostic variablesin soft tissue sarcoma

      BRITISH JOURNAL OF CANCER
    20. Depowski, PL; Brien, TP; Sheehan, CE; Stylos, S; Johnson, RL; Ross, JS
      Prognostic significance of p34(cdc2) cyclin-dependent kinase and MIB1 overexpression, and HER-2/neu gene amplification detected by fluorescence in situ hybridization in breast cancer

      AJCP. American journal of clinical pathology
    21. BORRE M; STRAUSBOLGRON B; NERSTROM B; OVERGAARD J
      IMMUNOHISTOCHEMICAL BCL-2 AND KI-67 EXPRESSION PREDICT SURVIVAL IN PROSTATE-CANCER PATIENTS FOLLOWED EXPECTANTLY

      PROSTATE CANCER AND PROSTATIC DISEASES
    22. MASUDA M; TAKANO Y; IKI M; ASAKURA T; HASHIBA T; NOGUCHI S; HOSAKA M
      PROGNOSTIC-SIGNIFICANCE OF KI-67, P53, AND BCL-2 EXPRESSION IN PROSTATE-CANCER PATIENTS WITH LYMPH-NODE METASTASES - A RETROSPECTIVE IMMUNOHISTOCHEMICAL ANALYSIS

      Pathology international
    23. MCCUTCHEON IE
      AGGRESSIVE PITUITARY-TUMORS - REVIEW

      Oncology
    24. KING KL; HWANG JJ; CHAU GY; TSAY SH; CHI CW; LEE TG; WU LH; WU CW; LUI WY
      KI-67 EXPRESSION AS A PROGNOSTIC MARKER IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA

      Journal of gastroenterology and hepatology
    25. BROLL R; MAHLKE C; BEST R; SCHIMMELPENNING H; STRIK MW; SCHIEDECK T; BRUCH HP; DUCHROW M
      ASSESSMENT OF THE PROLIFERATION INDEX IN GASTRIC CARCINOMAS WITH THE MONOCLONAL-ANTIBODY MIB-1

      Journal of cancer research and clinical oncology
    26. LOSA M; FRANZIN A; MORTINI P; TERRENI MR; MANGILI F; GIOVANELLI M
      USEFULNESS OF MARKERS OF CELL-PROLIFERATION IN THE MANAGEMENT OF PITUITARY-ADENOMAS

      Clinical science
    27. BORRE M; BENTZEN SM; NERSTROM B; OVERGAARD J
      TUMOR-CELL PROLIFERATION AND SURVIVAL IN PATIENTS WITH PROSTATE-CANCER FOLLOWED EXPECTANTLY

      The Journal of urology
    28. CHINO O; MAKUUCHI H; SHIMADA H; MACHIMURA T; MITOMI T; OSAMURA RY
      ASSESSMENT OF THE PROLIFERATIVE ACTIVITY OF SUPERFICIAL ESOPHAGEAL-CARCINOMA USING MIB-1 IMMUNOSTAINING FOR THE KI-67 ANTIGEN

      Journal of surgical oncology
    29. STAPLETON AMF; ZBELL P; KATTAN MW; YANG G; WHEELER TM; SCARDINO PT; THOMPSON TC
      ASSESSMENT OF THE BIOLOGIC MARKERS P53, KI-67, AND APOPTOTIC INDEX ASPREDICTIVE INDICATORS OF PROSTATE CARCINOMA RECURRENCE AFTER SURGERY

      Cancer
    30. JANSSON A; SUN XF
      KI-67 EXPRESSION IN RELATION TO CLINICOPATHOLOGICAL VARIABLES AND PROGNOSIS IN COLORECTAL ADENOCARCINOMAS

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    31. PALESTRO G; PONTI R; CHIUSA L; CHIARLE R; GEUNA M; NOVERO D; FREILONE R; PICH A
      CELL-PROLIFERATION, BCL-2, C-MYC, P53 AND APOPTOSIS AS INDICATORS OF DIFFERENT AGGRESSIVENESS IN SMALL LYMPHOCYTIC LYMPHOMA (SLL)

      European journal of haematology
    32. SUWA Y; TAKANO Y; IKI M; ASAKURA T; NOGUCHI S; MASUDA M
      PROGNOSTIC-SIGNIFICANCE OF KI-67 EXPRESSION IN TRANSITIONAL-CELL BLADDER-CARCINOMA AFTER RADICAL CYSTECTOMY

      Pathology research and practice
    33. MARX D; MEDEN H; BRUNE T; KRON M; KORABIOWSKA M; KUHN W; SCHAUER A
      MIB-1 EVALUATED PROLIFERATIVE ACTIVITY IN OVARIAN-CANCER WITH RESPECTTO PROGNOSTIC-SIGNIFICANCE

      Anticancer research
    34. BODEY B; BODEY B; GROGER AM; SIEGEL SE; KAISER HE
      CLINICAL AND PROGNOSTIC-SIGNIFICANCE OF KI-67 AND PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION IN CHILDHOOD PRIMITIVE NEUROECTODERMAL BRAIN-TUMORS

      Anticancer research
    35. JONES HL; DELAHUNT B; BETHWAITE PB; THORNTON A
      POLYCLONAL KI-67 EXPRESSION IN TRANSITIONAL-CELL CARCINOMA OF THE BLADDER

      Pathology
    36. ASAKURA T; TAKANO Y; IKI M; SUWA Y; NOGUCHI S; KUBOTA Y; MASUDA M
      PROGNOSTIC VALUE OF KI-67 FOR RECURRENCE AND PROGRESSION OF SUPERFICIAL BLADDER-CANCER

      The Journal of urology
    37. MOLINO A; MICCIOLO R; TURAZZA M; BONETTI F; PIUBELLO Q; BONETTI A; NORTILLI R; PELOSI G; CETTO GL
      KI-67 IMMUNOSTAINING IN 322 PRIMARY BREAST-CANCERS - ASSOCIATIONS WITH CLINICAL AND PATHOLOGICAL VARIABLES AND PROGNOSIS

      International journal of cancer
    38. BROWN RW; ALLRED DC; CLARK GM; OSBORNE CK; HILSENBECK SG
      PROGNOSTIC VALUE OF KI-67 COMPARED TO S-PHASE FRACTION IN AXILLARY NODE-NEGATIVE BREAST-CANCER

      Clinical cancer research
    39. DOMAGALA W; MARKIEWSKI M; HAREZGA B; DUKOWICZ A; OSBORN M
      PROGNOSTIC-SIGNIFICANCE OF TUMOR-CELL PROLIFERATION RATE AS DETERMINED BY THE MIB-1 ANTIBODY IN BREAST-CARCINOMA - ITS RELATIONSHIP WITH VIMENTIN AND P53 PROTEIN

      Clinical cancer research
    40. STONE CH; LYNCH EF; LINDEN MD; KUBUS JJ; ZARBO RJ
      IMMUNOCYTOCHEMICAL EVALUATION OF PROLIFERATING CELL NUCLEAR ANTIGEN, KI-67 (MIB-1), AND P53 IN PREDICTING SURVIVAL OF PRIMARY AND METASTATIC MALIGNANT MELANOMAS

      Applied immunohistochemistry
    41. JENSEN V; ANDERSEN J
      VALUE OF IMMUNOHISTOCHEMICAL-DETERMINED ESTROGEN-RECEPTOR STATUS AND PROLIFERATIVE ACTIVITY IN BREAST-CANCER - A RETROSPECTIVE STUDY INCLUDING PATIENTS TREATED BY ENDOCRINE THERAPY AT THE TIME OF RECURRENCE

      Breast
    42. HAROSKE G; DIMMER V; STEINDORF D; SCHILLING U; THEISSIG F; KUNZE KD
      CELLULAR SOCIOLOGY OF PROLIFERATING TUMOR-CELLS IN INVASIVE DUCTAL BREAST-CANCER

      Analytical and quantitative cytology and histology
    43. ROLAND NJ; ROWLEY H; SCRAGGS M; JOHNSON P; JONES AS
      MIB-1 AND INVOLUCRIN EXPRESSION IN LARYNGEAL SQUAMOUS CARCINOMA - THERELATIONSHIP TO HOST AND TUMOR FACTORS AND SURVIVAL

      Clinical otolaryngology and allied sciences
    44. LJUNG G; EGEVAD L; NORBERG M; DELATORRE M; HOLMBERG L; BUSCH C; NILSSON S
      ASSESSMENT OF PROLIFERATION INDICATORS IN RESIDUAL PROSTATIC ADENOCARCINOMA CELLS AFTER RADICAL EXTERNAL-BEAM RADIOTHERAPY

      The Prostate
    45. MASUDA M; IKI M; TAKANO Y; ASAKURA T; NOGUCHI S; IKEDA I; KUBOTA Y; HOSAKA M
      PROGNOSTIC-SIGNIFICANCE OF KI-67 LABELING INDEX IN UROTHELIAL TUMORS OF THE RENAL PELVIS AND URETER

      The Journal of urology
    46. BUBENDORF L; SAUTER G; MOCH H; SCHMID HP; GASSER TC; JORDAN P; MIHATSCH MJ
      KI67 LABELING INDEX - AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE-CANCER TREATED BY RADICAL PROSTATECTOMY

      Journal of pathology
    47. FENELEY MR; YOUNG MPA; CHINYAMA C; KIRBY RS; PARKINSON MC
      KI-67 EXPRESSION IN EARLY PROSTATE-CANCER AND ASSOCIATED PATHOLOGICALLESIONS

      Journal of Clinical Pathology
    48. KROS JM; HOP WCJ; GODSCHALK JJCJ; KRISHNADATH KK
      PROGNOSTIC VALUE OF THE PROLIFERATION-RELATED ANTIGEN KI-67 IN OLIGODENDROGLIOMAS

      Cancer
    49. HARBECK N; DETTMAR P; THOMSSEN C; PACHE L; ZIFFER P; FIZI K; JANICKE F; NATHRATH W; SCHMITT M; GRAEFF H
      PROGNOSTIC-SIGNIFICANCE OF 2 PROLIFERATIO N-ASSOCIATED FACTORS IN NODE-NEGATIVE BREAST-CANCER - S-PHASE AND MIB1 (KI-67)

      Gynakologisch-geburtshilfliche Rundschau
    50. BOCKER T; BITTINGER A; WIELAND W; BUETTNER R; FAUSER G; HOFSTAEDTER F; RUSCHOFF J
      IN-VITRO AND EX-VIVO EXPRESSION OF NUCLEOLAR PROTEINS B23 AND P120 INBENIGN AND MALIGNANT EPITHELIAL LESIONS OF THE PROSTATE

      Modern pathology
    51. BECK T; WELLER EE; WEIKEL W; BRUMM C; WILKENS C; KNAPSTEIN PG
      USEFULNESS OF IMMUNOHISTOCHEMICAL STAINING FOR P53 IN THE PROGNOSIS OF BREAST CARCINOMAS - CORRELATIONS WITH ESTABLISHED PROGNOSIS PARAMETERS AND WITH THE PROLIFERATION MARKER, MIB-1

      Gynecologic oncology
    52. GAFFNEY EV; HALPIN DP; BLAKEMORE WS
      RELATIONSHIP BETWEEN LOW ESTROGEN-RECEPTOR VALUES AND OTHER PROGNOSTIC FACTORS IN PRIMARY BREAST-TUMORS

      Surgery
    53. JENSEN V; LADEKARL M; HOLMNIELSEN P; MELSEN F; SOERENSEN FB
      THE PROGNOSTIC VALUE OF ONCOGENIC ANTIGEN-519 (OA-519) EXPRESSION ANDPROLIFERATIVE ACTIVITY DETECTIVE BY ANTIBODY MIB-1 IN NODE-NEGATIVE BREAST-CANCER

      Journal of pathology
    54. KRUGER S; MULLER H
      CORRELATION OF MORPHOMETRY, NUCLEOLAR ORGANIZER REGIONS, PROLIFERATING CELL NUCLEAR ANTIGEN AND KI67 ANTIGEN EXPRESSION WITH GRADING AND STAGING IN URINARY-BLADDER CARCINOMAS

      British Journal of Urology
    55. KIMURA N; WATANABE M; KUBOTA M; OONUMA T; MIZOKAMI A; NAGURA H
      QUANTITATIVE-ANALYSIS OF IMMUNOHISTOCHEMICAL ANDROGEN RECEPTOR AND KI-67 IN PROSTATIC-CARCINOMA AND ITS RELATIONSHIP TO HISTOLOGIC GRADE

      Oncology Reports
    56. KORABIOWSKA M; BRINCK U; HOENIG JF; BARTKOWSKI SB; MIRECKA J; SCHAUER A
      AN APPLICATION OF MIB ANTIBODY TO THE RETROSPECTIVE STUDY OF MELANOMAS OF ORAL-MUCOSA AND FACIAL SKIN

      Journal of cancer research and clinical oncology
    57. JONES AS; ROLAND NJ; CASLIN AW; COOKE TG; COOKE LD; FORSTER G
      A COMPARISON OF CELLULAR PROLIFERATION MARKERS IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      Journal of Laryngology and Otology
    58. PICH A; PONTI R; VALENTE G; CHIUSA L; GEUNA M; NOVERO D; PALESTRO G
      MIB-1, KI67, AND PCNA SCORES AND DNA FLOW-CYTOMETRY IN INTERMEDIATE GRADE MALIGNANT-LYMPHOMAS

      Journal of Clinical Pathology
    59. SILVESTRINI R
      PROLIFERATION MARKERS IN BREAST-CANCER

      European journal of cancer
    60. FRIERSON HF
      IMMUNOHISTOCHEMICAL ANALYSIS OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN INFILTRATING DUCTAL CARCINOMAS - COMPARISON WITH CLINICAL AND PATHOLOGICAL VARIABLES

      Modern pathology
    61. TUCCARI G; RIZZO A; GIUFFRE G; BARRESI G
      IMMUNOCYTOCHEMICAL DETECTION OF DNA TOPOISOMERASE TYPE-II IN PRIMARY BREAST CARCINOMAS - CORRELATION WITH CLINICOPATHOLOGICAL FEATURES

      Virchows Archiv. A. Pathological anatomy and histology
    62. MCLOUGHLIN J; FOSTER CS; PRICE P; WILLIAMS G; ABEL PD
      EVALUATION OF KI-67 MONOCLONAL-ANTIBODY AS PROGNOSTIC INDICATOR FOR PROSTATIC-CARCINOMA

      British Journal of Urology
    63. RAILO M; NORDLING S; VONBOGUSLAWSKY K; LEIVONEN M; KYLLONEN L; VONSMITTEN K
      PROGNOSTIC VALUE OF KI-67 IMMUNOLABELING IN PRIMARY OPERABLE BREAST-CANCER

      British Journal of Cancer
    64. PENCE JC; KERNS BJM; DODGE RK; IGLEHART JD
      PROGNOSTIC-SIGNIFICANCE OF THE PROLIFERATION INDEX IN SURGICALLY RESECTED NON-SMALL-CELL LUNG-CANCER

      Archives of surgery
    65. LINDEN MD; MA CK; KUBUS J; BROWN RD; ZARBO RJ
      KI-67 AND PROLIFERATING CELL NUCLEAR ANTIGEN TUMOR PROLIFERATIVE INDEXES IN DNA DIPLOID COLORECTAL ADENOCARCINOMAS - CORRELATION WITH HISTOPATHOLOGIC CHARACTERISTICS AND CELL-CYCLE ANALYSIS WITH 2-COLOR DNA FLOW-CYTOMETRY

      American journal of clinical pathology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 12:59:27